Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,317 INR | +1.60% | +4.50% | +10.36% |
Summary
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 59% by 2026.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With an expected P/E ratio at 59.24 and 50.84 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.36% | 1.58B | C- | ||
-36.66% | 13.17B | B+ | ||
+4.98% | 11.81B | B+ | ||
-4.50% | 11.28B | B | ||
+9.13% | 10.67B | B+ | ||
+12.65% | 7.14B | B- | ||
-10.56% | 7.13B | A- | ||
+9.12% | 6.5B | D | ||
+12.27% | 4.25B | B+ | ||
+32.50% | 4.09B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- RAINBOW Stock
- Ratings Rainbow Children's Medicare Limited